Stryker Corporation reported $25.8B of revenue over the trailing twelve months, +8.5% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $25.8B (to Q2 2026). Net Income: $3.73B, trailing twelve months to Q2 2026. Free Cash Flow: $4.70B, trailing twelve months to Q2 2026. Op Margin: 21%, trailing twelve months to Q2 2026.

SYKStryker Corporation

HealthcareUSD

$329.65

$282.5852 weeks$391.41

SYK as reported

Stryker Corporation reported $25.8B of revenue over the trailing twelve months, +8.5% on the year before. 11 reported series are charted on this page, each one as filed.

$25.8B

Revenue, trailing twelve months · to Q2 2026 · +8.5% against the twelve months before

Net Income: $3.73B
Net Income · +28% year on year · trailing twelve months to Q2 2026
Free Cash Flow: $4.70B
Free Cash Flow · +17% year on year · trailing twelve months to Q2 2026
Op Margin: 21%
Op Margin · trailing twelve months to Q2 2026

Every series Ryufin has for SYK, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$25.8B	+8.5%	Q2 2026
Net Income	$3.73B	+28%	Q2 2026
EPS	$9.65	+28%	Q2 2026
Gross Margin	65%	n/a	Q2 2026
Op Margin	21%	n/a	Q2 2026
Net Margin	14%	n/a	Q2 2026
ROE	15%	n/a	Q2 2026
ROA	7.0%	n/a	Q2 2026
ROIC	11%	n/a	Q2 2026
Free Cash Flow	$4.70B	+17%	Q2 2026
P/E	34.2	n/a	today